Internal Medicine, Nephrology · Rockville Centre, NY
NPI
1093790800
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
242 Merrick Rd, Suite 304
Rockville Centre, NY, 11570
Phone (516) 764-7070
Groups this clinician bills Medicare through
Medicare paid, 2024
$342K
7,102 services
Medicare patients, 2024
865
Average age 77
Drug cost, 2024
$1.3M
2,863 prescriptions
Company payments, 2025
$1,679
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas Lax was code 99232 (hospital e&m - subsequent), 624 times for 267 patients. In total Douglas Lax billed 7,102 services in 77 codes, and Medicare paid $342K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-10-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 624 | 267 | $69.47 | $43K |
| 99233 Hospital E&M - Subsequent | Facility | 614 | 256 | $104.25 | $64K |
| 99214 Office E&M - Established | Office | 465 | 237 | $87.90 | $41K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 341 | 59 | $53.38 | $18K |
| 36415 Venipuncture Blood Collection | Office | 247 | 197 | $8.53 | $2,107 |
| 80053 Clinical Chemistry | Office | 229 | 145 | $10.35 | $2,370 |
| 90960 ESRD Related Services (not dialysis) | Office | 214 | 92 | $294.19 | $63K |
| 85025 Blood Count | Office | 214 | 141 | $7.61 | $1,629 |
| 99223 Hospital E&M - Initial | Facility | 210 | 197 | $150.19 | $32K |
| 80061 Clinical Chemistry | Office | 187 | 120 | $13.12 | $2,453 |
| 83540 Clinical Chemistry | Office | 185 | 122 | $6.34 | $1,173 |
| 83970 Clinical Chemistry | Office | 185 | 117 | $40.45 | $7,483 |
| 83550 Clinical Chemistry | Office | 183 | 122 | $8.57 | $1,568 |
| 82728 Clinical Chemistry | Office | 183 | 121 | $13.36 | $2,445 |
| 99213 Office E&M - Established | Office | 165 | 130 | $61.91 | $10K |
By year: 2022 $328K for 4,937 services; 2023 $326K for 6,452 services; 2024 $342K for 7,102 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 247 | 197 | $8.53 | $2,107 |
| 80053 Clinical Chemistry | 229 | 145 | $10.35 | $2,370 |
| 85025 Blood Count | 214 | 141 | $7.61 | $1,629 |
| 80061 Clinical Chemistry | 187 | 120 | $13.12 | $2,453 |
| 83970 Clinical Chemistry | 185 | 117 | $40.45 | $7,483 |
| 83540 Clinical Chemistry | 185 | 122 | $6.34 | $1,173 |
| 83550 Clinical Chemistry | 183 | 122 | $8.57 | $1,568 |
| 82728 Clinical Chemistry | 183 | 121 | $13.36 | $2,445 |
| 83036 Blood Count | 155 | 109 | $9.52 | $1,476 |
| 84100 Clinical Chemistry | 92 | 81 | $4.65 | $428 |
Medicare prescription drug claims, 2024
In 2024, the drug Douglas Lax prescribed most often to Medicare patients was Amlodipine Besylate, with 156 prescriptions and refills. In total Douglas Lax wrote 2,863 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 156 | 345 | 52 | $1,077 |
| Farxiga Dapagliflozin Propanediol | 119 | 209 | 38 | $112K |
| Furosemide Generic | 93 | 223 | 37 | $595 |
| Torsemide Generic | 90 | 249 | 37 | $1,518 |
| Calcitriol Generic | 85 | 221 | 25 | $1,296 |
| Losartan Potassium Generic | 77 | 226 | 30 | $726 |
| Atorvastatin Calcium Generic | 73 | 188 | 28 | $856 |
| Allopurinol Generic | 70 | 208 | 25 | $716 |
| Carvedilol Generic | 70 | 171 | 18 | $549 |
| Chlorthalidone Generic | 64 | 103 | 12 | $1,024 |
| Metoprolol Succinate Generic | 50 | 146 | 20 | $962 |
| Sevelamer Carbonate Generic | 50 | 100 | 17 | $3,793 |
| Mounjaro Tirzepatide | 49 | 63 | Under 11 | $63K |
| Hydralazine Hcl Generic | 48 | 113 | 20 | $729 |
| Spironolactone Generic | 48 | 135 | 14 | $714 |
Brand drugs: 618 claims; generic drugs: 2,227 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas Lax $1,679 ($1,679 in general payments such as food, travel and fees) from 19 companies. The largest payer was Otsuka America Pharmaceutical, Inc. with $340.
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. 4578.T | 19 | $340 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $153 |
| Amgen Inc. AMGN | 6 | $139 |
| Ardelyx, Inc. ARDX | 5 | $122 |
| GlaxoSmithKline, LLC. GSK | 5 | $119 |
| Novo Nordisk Inc NVO | 5 | $118 |
| OPKO Pharmaceuticals, LLC | 4 | $77.49 |
| Mallinckrodt Hospital Products Inc. | 3 | $63.46 |
| Travere Therapeutics, Inc. TVTX | 2 | $63.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.